share_log

RBC Capital Reiterates Outperform on Surgery Partners, Maintains $49 Price Target

Benzinga ·  Aug 7 13:23  · Ratings

RBC Capital analyst Ben Hendrix reiterates Surgery Partners (NASDAQ:SGRY) with a Outperform and maintains $49 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment